Why is PubChem so useful for bioinformaticians?

The PubChem database serves as an invaluable resource for bioinformaticians engaged in molecular docking and dynamics simulation studies, offering a vast repository of chemical information essential for identifying and evaluating potential ligand candidates. With millions of unique chemical structures and extensive bioactivity data, PubChem facilitates the initial stages of drug discovery by providing readily accessible and computationally prepared ligand structures.

PubChem, maintained by the National Center for Biotechnology Information (NCBI), centralizes chemical information from hundreds of data sources, organizing it into various collections such as Substance, Compound, BioAssay, Protein, Gene, Pathway, and Patent. This interconnectedness allows researchers to explore relationships between chemicals, proteins, and biological pathways. As of 2023, PubChem contains information for over 110 million compounds and 293 million bioactivity data points for 3.6 million compounds across 1.4 million bioassays, demonstrating its extensive coverage for drug discovery efforts.

For molecular docking, which involves predicting how a ligand binds to a protein, and molecular dynamics simulations, which analyze the dynamic behavior of molecular systems, the quality and format of ligand structures are critical. PubChem addresses this by providing standardized and computationally ready 2D/3D ligand structures, including SMILES, InChI, SDF, and PDB-formatted files. These formats are crucial for cheminformatics, which translates complex molecular structures into machine-readable formats. SMILES (Simplified Molecular-Input Line-Entry System), for instance, converts 3D molecular structures into linear text strings, facilitating computational processing and analysis. Canonical SMILES ensures a unique representation for each molecule, which is vital for database integrity and machine learning applications.

A key advantage of PubChem for computational studies is its robust search capabilities, allowing users to find compounds by name, structure, substructure, similarity, or bioactivity. This enables targeted queries, such as searching for FDA-approved drugs or kinase inhibitors, utilizing tools like the Classification Browser or MeSH terms.

PubChem website interface accessed on 27 March 2026 via https://pubchem.ncbi.nlm.nih.gov/

On the PubChem website interface, it offers the “Draw” functionality, where users can import a very similar chemical structure (for instance downloaded SDF file) and draw/modify it to search whether the newly drawn structure has already been deposited in the PubChem database. Bear in mind that this is one of the ways for you to check and search for your desired chemical structure via PubChem, which I found it to incredibly useful as the names of the chemical structures written in the previous publications oftentimes have spelling mistakes, which might hinder you from finding your desired chemical structure. Also, there is a “ID file” functionality offered by PubChem which enables the users to write the PubChem CID (compound identifier) line by line (one PubChem CID per line) to download all the desired chemical structures in bulk.

The database also provides pre-computed 3D conformers, which are essential for docking simulations without requiring extensive manual optimization. Researchers can filter results by “3D Conformer Available” and “Standardized” to ensure they obtain appropriate structures for their analyses. For instance, the PubChemQC B3LYP/6–31G*//PM6 dataset offers electronic properties for nearly 86 million molecules, calculated using advanced quantum chemical methods, further enhancing the utility of PubChem for detailed computational studies.

Downloading compound sets in bulk is another crucial feature, supported through mechanisms like PUG-REST or FTP. This capability is particularly useful for virtual screening campaigns, where millions of compounds may be evaluated against a target protein. For example, researchers have screened over 111 million unique compounds in PubChem for novel HIV protease inhibitors using pharmacophore-based similarity searches. Another study involving SARS-CoV-2 focused on docking 1.4 billion molecules against multiple viral targets using platforms like AutoDock-GPU, demonstrating the scale of virtual screening possible with such extensive databases.

Integrating PubChem with other NCBI resources, such as PubMed and BioAssay, allows for prioritizing ligands with experimental activity. This integration helps in identifying compounds with known biological effects, reducing the experimental burden and accelerating the discovery process. The use of standardized curation, including stereochemistry and tautomer handling, significantly reduces the preprocessing overhead typically associated with preparing ligands for molecular simulations.

For effective utilization of PubChem in molecular docking and dynamics simulations, several steps are recommended:

1. Targeted Queries: Begin with specific searches using keywords, chemical structures, or bioactivity data to narrow down the vast number of compounds.
2. Filtering for Quality: Filter compounds by criteria such as “3D Conformer Available” and “Standardized” to ensure high-quality, pre-optimized structures are selected.
3. Download Formats: Download SDF (Structure-Data File) files, which contain explicit hydrogens and minimized geometries suitable for direct use in most docking software.
4. Validation and Parameterization: Before performing docking or molecular dynamics, it is often necessary to validate and re-parameterize ligands using tools like ACPYPE or ANTECHAMBER to ensure compatibility with specific simulation force fields.
5. Citing PubChem: Always cite PubChem appropriately in research to acknowledge its contribution to the study.

Molecular docking involves generating potential ligand poses within a protein’s binding site and evaluating their stability. The “search problem” in docking aims to efficiently explore the vast conformational space of ligands and their orientations, while the “scoring problem” evaluates the binding affinity of each pose. High-resolution protein structures are critical inputs for accurate docking simulations, as they precisely define the binding site. Protein flexibility is a significant challenge, with approaches like ensemble docking used to account for conformational changes in the protein upon ligand binding. Molecular dynamics simulations extend docking by simulating the time-dependent movement of atoms and molecules, providing insights into binding stability, conformational changes, and kinetic properties. This combined approach is frequently used to identify novel drug candidates for various targets, including SARS-CoV-2 proteases, HIV protease, and various kinases.

The integration of PubChem with advanced computational techniques like deep learning further enhances its utility in drug discovery. Deep learning methods are increasingly used to improve scoring functions in molecular docking, train on large datasets, and explore conformational spaces more efficiently. Generative AI, for example, can be used to construct new drug-like compound databases for virtual screening, learning from existing compounds in databases like DrugBank to create novel molecules with desired properties. These AI-driven approaches, combined with the comprehensive data provided by PubChem, are revolutionizing drug discovery by accelerating the identification of potential drug candidates and improving the prediction of ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity) properties.

In summary, PubChem is an indispensable resource for bioinformaticians. Its vast collection of compounds, coupled with detailed structural and bioactivity information, makes it a cornerstone for modern molecular docking and dynamics simulation studies. By effectively leveraging its data and tools, researchers can significantly accelerate the discovery and development of new therapeutics.